ARCHIVES

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

NBCC Sees $2.6 billion for Breast Cancer By Year 2000, Begins Voter Registration Drive

May 10, 1996

Program Announcement For Clinical Research

February 29, 1980

Obituary: Lee Wattenberg, 92, “Father of Chemoprevention”

December 12, 2014

Cancer Centers Begin Free Genetic Tumor Testing Project For Lung Cancer Patients

October 30, 2009

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014